ANAGENICS LIMITED — Director's Dealing 2016

Oct 16, 2016

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Cellmid Limited ABN 69 111 304 119

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr David King
Date of last notice	19 November 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest	Seistend Pty Ltd
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.	Seistend Pty Ltd
Date of change	17 October 2016
No. of securities held prior to change	22,500,000 fully paid ordinary shares
	11,250,000 Listed Options
	(Exp. 23/10/16 ex price $0.034)
	4,000,000Unlisted Options $0.06 Exp.19/11/18
Class	Listed Options at $0.034 Exp. 23/10/16
	FullyPaid OrdinaryShares
Number acquired	1,500,000 Fully Paid Ordinary Shares converted
	from Listed Options
Number disposed	1,250,000 Listed Options
	1,500,000 Listed Options on conversion to Fully
	Paid Ordinary Shares
Value/Consideration	Disposal of Listed Options - $2.00
Note: If consideration is non-cash, provide details and estimated valuation	Conversion of Listed Options to Fully Paid
	Ordinary Shares-$51,000

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change 24,000,000 fully paid ordinary shares 8,500,000 Listed Options (Exp. 23/10/16 ex price $0.034) 4,000,000 Unlisted Options $0.06 Exp. 19/11/18 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of Off-Market Transfer and Exercise of Options. securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior written**clearance was required? **	No
If so, was prior written clearance provided to allow the tradeto proceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3